Sorry, you need javascript enabled to view this content

PerkinElmer is a global leader focused on improving the health and safety of people and the environment. Our dedicated team of 7,600 employees worldwide are passionate about providing customers with an unmatched experience as they help solve critical issues in human and environmental health.  Our innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and expertise, enable customers to transform data into insights – accelerating science to better protect our environment, our food supply and the health of our families.

Key Facts

Mission:
Improving the health and safety of people and the environment

Ticker Symbol:
PKI (NYSE)

2013 Revenue:
Approximately $2.2 billion

Chairman & CEO:
Robert F. Friel

Capabilities:
Detection
Imaging
Informatics
Services

Serving:
Diagnostics
Life Sciences
Environmental & Applied Markets

Global Headquarters:
Waltham, MA

Number of Patents:
3,300

By the Numbers

Together, we are making a difference for the better:

  • For more effective drugs: PerkinElmer technologies and expertise were instrumental in the development of 22 novel therapeutic drugs.
  • For healthier babies: Our neonatal and newborn screening technologies have aided in screening 450 million babies worldwide for a variety of life-threatening diseases, helping them get a healthier start.
  • For better treatment: We touch over one million lives every year through cancer treatment with our advances in digital imaging technology.
  • For a cleaner and safer environment: Our instrumentation and solutions help to detect and analyze approximately 2.25 billion air, water, and soil samples to support ensuring safety standards and detecting environmental threats.
  • For more informed scientific decisions: Serving over two million scientists worldwide with our electronic laboratory notebook and software.

*PerkinElmer conducts business in nearly every country across the globe.

*Excluding the following countries that are currently restricted due to embargo and/or sanctions: Cuba, Iran, North Korea, Sudan and Syria